Rank | Gene Set | Z-score |
---|---|---|
1 | keratinocyte differentiation (GO:0030216) | 8.98422283 |
2 | molting cycle (GO:0042303) | 8.64533364 |
3 | hair cycle (GO:0042633) | 8.64533364 |
4 | water homeostasis (GO:0030104) | 8.43828746 |
5 | epidermal cell differentiation (GO:0009913) | 7.33972115 |
6 | L-phenylalanine catabolic process (GO:0006559) | 7.11214310 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.11214310 |
8 | L-phenylalanine metabolic process (GO:0006558) | 6.76809042 |
9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.76809042 |
10 | aromatic amino acid family catabolic process (GO:0009074) | 6.48817781 |
11 | intermediate filament organization (GO:0045109) | 6.40929827 |
12 | peptide cross-linking (GO:0018149) | 6.39627787 |
13 | epidermis development (GO:0008544) | 6.37974587 |
14 | tryptophan catabolic process (GO:0006569) | 6.07409807 |
15 | indole-containing compound catabolic process (GO:0042436) | 6.07409807 |
16 | indolalkylamine catabolic process (GO:0046218) | 6.07409807 |
17 | phospholipid efflux (GO:0033700) | 5.97210035 |
18 | kynurenine metabolic process (GO:0070189) | 5.94128825 |
19 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.90327518 |
20 | establishment of skin barrier (GO:0061436) | 5.87092897 |
21 | bile acid biosynthetic process (GO:0006699) | 5.85964233 |
22 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.71705881 |
23 | tryptophan metabolic process (GO:0006568) | 5.66751138 |
24 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.63314655 |
25 | high-density lipoprotein particle remodeling (GO:0034375) | 5.54498780 |
26 | glyoxylate metabolic process (GO:0046487) | 5.50593242 |
27 | complement activation, alternative pathway (GO:0006957) | 5.47773731 |
28 | regulation of protein activation cascade (GO:2000257) | 5.37641992 |
29 | urea cycle (GO:0000050) | 5.35189624 |
30 | urea metabolic process (GO:0019627) | 5.35189624 |
31 | negative regulation of fibrinolysis (GO:0051918) | 5.14367244 |
32 | alpha-linolenic acid metabolic process (GO:0036109) | 5.13876354 |
33 | regulation of fibrinolysis (GO:0051917) | 5.10506102 |
34 | regulation of complement activation (GO:0030449) | 5.09722577 |
35 | skin morphogenesis (GO:0043589) | 5.07010271 |
36 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.05355979 |
37 | protein carboxylation (GO:0018214) | 5.05355979 |
38 | sulfur amino acid catabolic process (GO:0000098) | 4.97567090 |
39 | imidazole-containing compound metabolic process (GO:0052803) | 4.93741184 |
40 | regulation of water loss via skin (GO:0033561) | 4.93132936 |
41 | nitrogen cycle metabolic process (GO:0071941) | 4.89573869 |
42 | regulation of triglyceride catabolic process (GO:0010896) | 4.83277949 |
43 | bile acid metabolic process (GO:0008206) | 4.79908189 |
44 | reverse cholesterol transport (GO:0043691) | 4.77920727 |
45 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.77307293 |
46 | lipoxygenase pathway (GO:0019372) | 4.73868312 |
47 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.71485811 |
48 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 4.67431642 |
49 | cysteine metabolic process (GO:0006534) | 4.67128476 |
50 | aromatic amino acid family metabolic process (GO:0009072) | 4.65014646 |
51 | protein-lipid complex remodeling (GO:0034368) | 4.60529211 |
52 | macromolecular complex remodeling (GO:0034367) | 4.60529211 |
53 | plasma lipoprotein particle remodeling (GO:0034369) | 4.60529211 |
54 | serine family amino acid catabolic process (GO:0009071) | 4.60261425 |
55 | triglyceride homeostasis (GO:0070328) | 4.55154758 |
56 | acylglycerol homeostasis (GO:0055090) | 4.55154758 |
57 | coenzyme catabolic process (GO:0009109) | 4.49565955 |
58 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 4.48606712 |
59 | intermediate filament cytoskeleton organization (GO:0045104) | 4.45717665 |
60 | keratinocyte development (GO:0003334) | 4.35644458 |
61 | regulation of cholesterol esterification (GO:0010872) | 4.34733632 |
62 | alpha-amino acid catabolic process (GO:1901606) | 4.33820987 |
63 | amino-acid betaine metabolic process (GO:0006577) | 4.33048691 |
64 | tyrosine metabolic process (GO:0006570) | 4.32866518 |
65 | linoleic acid metabolic process (GO:0043651) | 4.30788463 |
66 | intermediate filament-based process (GO:0045103) | 4.30300729 |
67 | homocysteine metabolic process (GO:0050667) | 4.27701713 |
68 | indolalkylamine metabolic process (GO:0006586) | 4.24189274 |
69 | glutamate metabolic process (GO:0006536) | 4.22992160 |
70 | bile acid and bile salt transport (GO:0015721) | 4.22290057 |
71 | fatty acid elongation (GO:0030497) | 4.20569998 |
72 | lysine metabolic process (GO:0006553) | 4.18115604 |
73 | lysine catabolic process (GO:0006554) | 4.18115604 |
74 | hemidesmosome assembly (GO:0031581) | 4.15295376 |
75 | cytolysis (GO:0019835) | 4.14748867 |
76 | negative regulation of sterol transport (GO:0032372) | 4.14515672 |
77 | negative regulation of cholesterol transport (GO:0032375) | 4.14515672 |
78 | cholesterol efflux (GO:0033344) | 4.12327084 |
79 | fibrinolysis (GO:0042730) | 4.11201837 |
80 | cellular biogenic amine catabolic process (GO:0042402) | 4.11191012 |
81 | amine catabolic process (GO:0009310) | 4.11191012 |
82 | cellular ketone body metabolic process (GO:0046950) | 4.07588491 |
83 | plasma lipoprotein particle clearance (GO:0034381) | 4.06011930 |
84 | glycine metabolic process (GO:0006544) | 4.05218057 |
85 | cellular amino acid catabolic process (GO:0009063) | 4.00185301 |
86 | cellular glucuronidation (GO:0052695) | 3.93795968 |
87 | cellular modified amino acid catabolic process (GO:0042219) | 3.92338289 |
88 | ethanol oxidation (GO:0006069) | 3.89729733 |
89 | benzene-containing compound metabolic process (GO:0042537) | 3.88925742 |
90 | complement activation, classical pathway (GO:0006958) | 3.84728824 |
91 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.83755722 |
92 | complement activation (GO:0006956) | 3.78732594 |
93 | arginine metabolic process (GO:0006525) | 3.77341010 |
94 | serine family amino acid metabolic process (GO:0009069) | 3.76895171 |
95 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.74880872 |
96 | regulation of cholesterol homeostasis (GO:2000188) | 3.69040997 |
97 | protein activation cascade (GO:0072376) | 3.68960727 |
98 | very long-chain fatty acid metabolic process (GO:0000038) | 3.67484165 |
99 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 3.67477309 |
100 | cofactor catabolic process (GO:0051187) | 3.66502476 |
101 | polarized epithelial cell differentiation (GO:0030859) | 3.65754606 |
102 | positive regulation of glomerulus development (GO:0090193) | 3.65456347 |
103 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.64078945 |
104 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.64078945 |
105 | negative regulation of lipase activity (GO:0060192) | 3.63003539 |
106 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.60993649 |
107 | blood coagulation, intrinsic pathway (GO:0007597) | 3.60899997 |
108 | regulation of keratinocyte differentiation (GO:0045616) | 3.60173235 |
109 | acetyl-CoA metabolic process (GO:0006084) | 3.57489413 |
110 | plasma lipoprotein particle assembly (GO:0034377) | 3.56148741 |
111 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.51825792 |
112 | aldehyde catabolic process (GO:0046185) | 3.51819571 |
113 | ketone body metabolic process (GO:1902224) | 3.51048062 |
114 | glucuronate metabolic process (GO:0019585) | 3.50784175 |
115 | uronic acid metabolic process (GO:0006063) | 3.50784175 |
116 | positive regulation of lipid catabolic process (GO:0050996) | 3.49672308 |
117 | serine family amino acid biosynthetic process (GO:0009070) | 3.48693449 |
118 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.48018682 |
119 | keratinization (GO:0031424) | 3.46479765 |
120 | organic acid catabolic process (GO:0016054) | 3.44962625 |
121 | carboxylic acid catabolic process (GO:0046395) | 3.44962625 |
122 | plasma lipoprotein particle organization (GO:0071827) | 3.43553939 |
123 | cholesterol homeostasis (GO:0042632) | 3.43018997 |
124 | low-density lipoprotein particle remodeling (GO:0034374) | 3.42753616 |
125 | phospholipid homeostasis (GO:0055091) | 3.41197825 |
126 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.40202199 |
127 | regulation of bile acid biosynthetic process (GO:0070857) | 3.38308267 |
128 | hair follicle morphogenesis (GO:0031069) | 3.37995878 |
129 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 3.34021010 |
130 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.24904598 |
131 | retinol metabolic process (GO:0042572) | 3.23205366 |
132 | defense response to fungus (GO:0050832) | 3.22227321 |
133 | gap junction assembly (GO:0016264) | 3.19803407 |
134 | surfactant homeostasis (GO:0043129) | 3.18825123 |
135 | positive regulation of transforming growth factor beta production (GO:0071636) | 3.18450290 |
136 | lateral sprouting from an epithelium (GO:0060601) | 3.17876270 |
137 | establishment of tissue polarity (GO:0007164) | 3.16780741 |
138 | establishment of planar polarity (GO:0001736) | 3.16780741 |
139 | positive regulation of humoral immune response (GO:0002922) | 3.14498784 |
140 | epithelium development (GO:0060429) | 3.14002967 |
141 | detection of bacterium (GO:0016045) | 3.11004946 |
142 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.04353549 |
143 | positive regulation of p38MAPK cascade (GO:1900745) | 3.00080683 |
144 | phospholipid catabolic process (GO:0009395) | 2.99706901 |
145 | ectoderm development (GO:0007398) | 2.97861224 |
146 | ceramide biosynthetic process (GO:0046513) | 2.97408938 |
147 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.95541939 |
148 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.95063593 |
149 | positive regulation of cholesterol efflux (GO:0010875) | 2.93290627 |
150 | positive regulation of chemokine secretion (GO:0090197) | 2.93061123 |
151 | chemical homeostasis within a tissue (GO:0048875) | 2.92207705 |
152 | phosphatidylserine metabolic process (GO:0006658) | 2.91518096 |
153 | polyol transport (GO:0015791) | 2.87155002 |
154 | regulation of chemokine secretion (GO:0090196) | 2.85068813 |
155 | positive regulation of epidermis development (GO:0045684) | 2.81280274 |
156 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.79956253 |
157 | response to phenylpropanoid (GO:0080184) | 2.79309526 |
158 | negative regulation of interferon-gamma production (GO:0032689) | 2.79001807 |
159 | detection of other organism (GO:0098543) | 2.73657666 |
160 | defense response to Gram-negative bacterium (GO:0050829) | 2.68054060 |
161 | regulation of epidermis development (GO:0045682) | 2.67117675 |
162 | regulation of epidermal cell differentiation (GO:0045604) | 2.66589520 |
163 | epithelial cell proliferation (GO:0050673) | 2.65411618 |
164 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.62639274 |
165 | primary alcohol metabolic process (GO:0034308) | 2.59434926 |
166 | positive regulation of cholesterol transport (GO:0032376) | 2.57344176 |
167 | positive regulation of sterol transport (GO:0032373) | 2.57344176 |
168 | hair cycle process (GO:0022405) | 2.55667430 |
169 | molting cycle process (GO:0022404) | 2.55667430 |
170 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.55228169 |
171 | lung epithelium development (GO:0060428) | 2.54866492 |
172 | regulation of cellular amide metabolic process (GO:0034248) | 2.51248701 |
173 | regulation of axon regeneration (GO:0048679) | 2.51112412 |
174 | regulation of neuron projection regeneration (GO:0070570) | 2.51112412 |
175 | positive regulation of collagen biosynthetic process (GO:0032967) | 2.50028863 |
176 | low-density lipoprotein particle clearance (GO:0034383) | 2.45635647 |
177 | regulation of glomerulus development (GO:0090192) | 2.44228195 |
178 | alditol phosphate metabolic process (GO:0052646) | 2.42029849 |
179 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.40125997 |
180 | negative regulation of heart growth (GO:0061117) | 2.40125997 |
181 | desmosome organization (GO:0002934) | 13.3476362 |
182 | keratinocyte proliferation (GO:0043616) | 10.3172759 |
183 | multicellular organismal water homeostasis (GO:0050891) | 10.0847780 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.31378666 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.41754534 |
3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.37495982 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.74900011 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.73542839 |
6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.35565878 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.10606244 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.74851215 |
9 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.35203245 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.95881452 |
11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.78691927 |
12 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.53343786 |
13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.52766006 |
14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.34445023 |
15 | RXR_22108803_ChIP-Seq_LS180_Human | 2.12420329 |
16 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.03527022 |
17 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.03527022 |
18 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.03473515 |
19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.5223813 |
20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.80030161 |
21 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.77729395 |
22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.76647711 |
23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71126947 |
24 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.67726559 |
25 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.66408109 |
26 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.65880495 |
27 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.50064205 |
28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.48603345 |
29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.48151772 |
30 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.41797746 |
31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.40386408 |
32 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.37627446 |
33 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.34849860 |
34 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.34648271 |
35 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30899917 |
36 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.22574882 |
37 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18376619 |
38 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.16960790 |
39 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.15574496 |
40 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.12976683 |
41 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.12258957 |
42 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.11901456 |
43 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.11540483 |
44 | ATF3_27146783_Chip-Seq_COLON_Human | 1.11439526 |
45 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.10313166 |
46 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.09865366 |
47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08690546 |
48 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.08677815 |
49 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07919941 |
50 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05569580 |
51 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.04143832 |
52 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02047830 |
53 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.00784077 |
54 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.00508977 |
55 | TP53_16413492_ChIP-PET_HCT116_Human | 0.99118294 |
56 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98043185 |
57 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.97811803 |
58 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.95136374 |
59 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.94126926 |
60 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.93561398 |
61 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.89178054 |
62 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.88483254 |
63 | CJUN_26792858_Chip-Seq_BT549_Human | 0.87232713 |
64 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86670691 |
65 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.86269943 |
66 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.86211371 |
67 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85565716 |
68 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.85282861 |
69 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.83675790 |
70 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.81750907 |
71 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.81269940 |
72 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.81175372 |
73 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.81042676 |
74 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.80788177 |
75 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.79823835 |
76 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.79447884 |
77 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.78275667 |
78 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.77858210 |
79 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.76422924 |
80 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.76413238 |
81 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.76335396 |
82 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.75858322 |
83 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.75796237 |
84 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75670044 |
85 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.74559923 |
86 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74159443 |
87 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.73350480 |
88 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.73298654 |
89 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.73129732 |
90 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.71256669 |
91 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.70791321 |
92 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70490555 |
93 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.70337504 |
94 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.70337504 |
95 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70027070 |
96 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.69591704 |
97 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.68705035 |
98 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.68090440 |
99 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67980473 |
100 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.67266127 |
101 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.65941800 |
102 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.65807334 |
103 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.65416740 |
104 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.64030390 |
105 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.62883177 |
106 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.62667438 |
107 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.62370899 |
108 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.62359418 |
109 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.62294168 |
110 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.61748287 |
111 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.61503118 |
112 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.61251704 |
113 | CBP_21632823_ChIP-Seq_H3396_Human | 0.57216842 |
114 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.57004209 |
115 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.56692189 |
116 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.56627190 |
117 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55354733 |
118 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55269203 |
119 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.54720596 |
120 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.54538383 |
121 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.54519639 |
122 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.54102539 |
123 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.54079486 |
124 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.53639603 |
125 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.53034497 |
126 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.52850432 |
127 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.52757582 |
128 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.51332742 |
129 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.51321226 |
130 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.51204435 |
131 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.51093086 |
132 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.49866007 |
133 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.49131706 |
134 | ERA_21632823_ChIP-Seq_H3396_Human | 0.49125530 |
135 | AR_20517297_ChIP-Seq_VCAP_Human | 0.49075635 |
136 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.49018849 |
137 | GATA2_19941826_ChIP-Seq_K562_Human | 0.48924982 |
138 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.48916966 |
139 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.48617482 |
140 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.47812477 |
141 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.47103293 |
142 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.46529833 |
143 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.46430370 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.00206436 |
2 | MP0005360_urolithiasis | 6.34564677 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.49531686 |
4 | MP0005365_abnormal_bile_salt | 5.17255015 |
5 | MP0002796_impaired_skin_barrier | 4.50954298 |
6 | MP0005451_abnormal_body_composition | 3.96960505 |
7 | MP0010234_abnormal_vibrissa_follicle | 3.93160046 |
8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.84802285 |
9 | MP0003191_abnormal_cellular_cholesterol | 3.71842959 |
10 | MP0003806_abnormal_nucleotide_metabolis | 3.53141983 |
11 | MP0003252_abnormal_bile_duct | 3.50775611 |
12 | MP0000566_synostosis | 3.18816585 |
13 | MP0001188_hyperpigmentation | 2.99128398 |
14 | MP0010329_abnormal_lipoprotein_level | 2.99003095 |
15 | MP0005275_abnormal_skin_tensile | 2.64563661 |
16 | MP0009840_abnormal_foam_cell | 2.53726233 |
17 | MP0005501_abnormal_skin_physiology | 2.50748739 |
18 | MP0003941_abnormal_skin_development | 2.48577766 |
19 | MP0003195_calcinosis | 2.45865369 |
20 | MP0000015_abnormal_ear_pigmentation | 2.35363636 |
21 | MP0005083_abnormal_biliary_tract | 2.25483297 |
22 | MP0001666_abnormal_nutrient_absorption | 2.24652080 |
23 | MP0004381_abnormal_hair_follicle | 2.22691664 |
24 | MP0005174_abnormal_tail_pigmentation | 2.18669082 |
25 | MP0005332_abnormal_amino_acid | 2.16058963 |
26 | MP0002095_abnormal_skin_pigmentation | 2.11358079 |
27 | MP0004019_abnormal_vitamin_homeostasis | 1.82078641 |
28 | MP0002118_abnormal_lipid_homeostasis | 1.81998732 |
29 | MP0005409_darkened_coat_color | 1.80205081 |
30 | MP0000609_abnormal_liver_physiology | 1.78671152 |
31 | MP0002060_abnormal_skin_morphology | 1.67839653 |
32 | MP0002254_reproductive_system_inflammat | 1.66314066 |
33 | MP0004947_skin_inflammation | 1.66125547 |
34 | MP0002138_abnormal_hepatobiliary_system | 1.47554789 |
35 | MP0003868_abnormal_feces_composition | 1.43862067 |
36 | MP0005319_abnormal_enzyme/_coenzyme | 1.41812676 |
37 | MP0001216_abnormal_epidermal_layer | 1.38117982 |
38 | MP0004782_abnormal_surfactant_physiolog | 1.36904656 |
39 | MP0010771_integument_phenotype | 1.34656529 |
40 | MP0003705_abnormal_hypodermis_morpholog | 1.34150799 |
41 | MP0010678_abnormal_skin_adnexa | 1.30075664 |
42 | MP0000647_abnormal_sebaceous_gland | 1.20710987 |
43 | MP0001764_abnormal_homeostasis | 1.17227163 |
44 | MP0005647_abnormal_sex_gland | 1.16674638 |
45 | MP0000579_abnormal_nail_morphology | 1.14142041 |
46 | MP0003011_delayed_dark_adaptation | 1.14109832 |
47 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.10753797 |
48 | MP0009697_abnormal_copulation | 1.06556343 |
49 | MP0009780_abnormal_chondrocyte_physiolo | 1.04329626 |
50 | MP0003566_abnormal_cell_adhesion | 1.02644140 |
51 | MP0002098_abnormal_vibrissa_morphology | 1.00997371 |
52 | MP0003950_abnormal_plasma_membrane | 0.98913834 |
53 | MP0002876_abnormal_thyroid_physiology | 0.98881289 |
54 | MP0000604_amyloidosis | 0.96171155 |
55 | MP0003453_abnormal_keratinocyte_physiol | 0.95962390 |
56 | MP0002177_abnormal_outer_ear | 0.94467641 |
57 | MP0000427_abnormal_hair_cycle | 0.93377475 |
58 | MP0009643_abnormal_urine_homeostasis | 0.90720114 |
59 | MP0009764_decreased_sensitivity_to | 0.90300092 |
60 | MP0000377_abnormal_hair_follicle | 0.89891439 |
61 | MP0001984_abnormal_olfaction | 0.88564150 |
62 | MP0009931_abnormal_skin_appearance | 0.87994310 |
63 | MP0010368_abnormal_lymphatic_system | 0.85579200 |
64 | MP0004185_abnormal_adipocyte_glucose | 0.85542892 |
65 | MP0000762_abnormal_tongue_morphology | 0.80569022 |
66 | MP0009379_abnormal_foot_pigmentation | 0.79956396 |
67 | MP0003656_abnormal_erythrocyte_physiolo | 0.79276788 |
68 | MP0000598_abnormal_liver_morphology | 0.78047972 |
69 | MP0003329_amyloid_beta_deposits | 0.77427117 |
70 | MP0003186_abnormal_redox_activity | 0.77263528 |
71 | MP0001191_abnormal_skin_condition | 0.75464994 |
72 | MP0005670_abnormal_white_adipose | 0.72337691 |
73 | MP0009763_increased_sensitivity_to | 0.72202395 |
74 | MP0005636_abnormal_mineral_homeostasis | 0.70456658 |
75 | MP0001784_abnormal_fluid_regulation | 0.68110243 |
76 | MP0002009_preneoplasia | 0.67816508 |
77 | MP0008469_abnormal_protein_level | 0.67319434 |
78 | MP0001851_eye_inflammation | 0.65176004 |
79 | MP0009765_abnormal_xenobiotic_induced | 0.63449822 |
80 | MP0002971_abnormal_brown_adipose | 0.63139245 |
81 | MP0009642_abnormal_blood_homeostasis | 0.62811536 |
82 | MP0001243_abnormal_dermal_layer | 0.62437186 |
83 | MP0005408_hypopigmentation | 0.61792079 |
84 | MP0009384_cardiac_valve_regurgitation | 0.60822032 |
85 | MP0005023_abnormal_wound_healing | 0.59117745 |
86 | MP0000465_gastrointestinal_hemorrhage | 0.58135828 |
87 | MP0005220_abnormal_exocrine_pancreas | 0.57179596 |
88 | MP0010030_abnormal_orbit_morphology | 0.55595368 |
89 | MP0000383_abnormal_hair_follicle | 0.55404771 |
90 | MP0005257_abnormal_intraocular_pressure | 0.55150049 |
91 | MP0002822_catalepsy | 0.54989920 |
92 | MP0003878_abnormal_ear_physiology | 0.54541234 |
93 | MP0005377_hearing/vestibular/ear_phenot | 0.54541234 |
94 | MP0005666_abnormal_adipose_tissue | 0.54311891 |
95 | MP0000367_abnormal_coat/_hair | 0.52977977 |
96 | MP0005334_abnormal_fat_pad | 0.52808935 |
97 | MP0004130_abnormal_muscle_cell | 0.52440820 |
98 | MP0001340_abnormal_eyelid_morphology | 0.51034478 |
99 | MP0002078_abnormal_glucose_homeostasis | 0.50918177 |
100 | MP0009672_abnormal_birth_weight | 0.49885337 |
101 | MP0009053_abnormal_anal_canal | 0.49594674 |
102 | MP0005376_homeostasis/metabolism_phenot | 0.49357539 |
103 | MP0005535_abnormal_body_temperature | 0.48494993 |
104 | MP0000467_abnormal_esophagus_morphology | 0.47706250 |
105 | MP0003638_abnormal_response/metabolism_ | 0.46328713 |
106 | MP0005187_abnormal_penis_morphology | 0.44602089 |
107 | MP0005075_abnormal_melanosome_morpholog | 0.44039096 |
108 | MP0003690_abnormal_glial_cell | 0.44022121 |
109 | MP0002089_abnormal_postnatal_growth/wei | 0.43100003 |
110 | MP0009333_abnormal_splenocyte_physiolog | 0.42842921 |
111 | MP0006036_abnormal_mitochondrial_physio | 0.41895977 |
112 | MP0004264_abnormal_extraembryonic_tissu | 0.40791116 |
113 | MP0005076_abnormal_cell_differentiation | 0.39572067 |
114 | MP0004272_abnormal_basement_membrane | 0.39474766 |
115 | MP0002090_abnormal_vision | 0.39461873 |
116 | MP0002132_abnormal_respiratory_system | 0.39228987 |
117 | MP0005266_abnormal_metabolism | 0.39085152 |
118 | MP0005171_absent_coat_pigmentation | 0.37869256 |
119 | MP0001186_pigmentation_phenotype | 0.37207598 |
120 | MP0005448_abnormal_energy_balance | 0.37011287 |
121 | MP0008961_abnormal_basal_metabolism | 0.36572355 |
122 | MP0001177_atelectasis | 0.35780291 |
123 | MP0003718_maternal_effect | 0.35225866 |
124 | MP0002233_abnormal_nose_morphology | 0.35181023 |
125 | MP0005084_abnormal_gallbladder_morpholo | 0.34480091 |
126 | MP0008873_increased_physiological_sensi | 0.34112486 |
127 | MP0003075_altered_response_to | 0.31793372 |
128 | MP0001756_abnormal_urination | 0.31250815 |
129 | MP0002111_abnormal_tail_morphology | 0.31192445 |
130 | MP0002282_abnormal_trachea_morphology | 0.31177074 |
131 | MP0000372_irregular_coat_pigmentation | 0.31134224 |
132 | MP0008874_decreased_physiological_sensi | 0.31091128 |
133 | MP0005166_decreased_susceptibility_to | 0.29506184 |
134 | MP0000428_abnormal_craniofacial_morphol | 0.29012321 |
135 | MP0003122_maternal_imprinting | 0.27837656 |
136 | MP0002166_altered_tumor_susceptibility | 0.27372265 |
137 | MP0000627_abnormal_mammary_gland | 0.27285372 |
138 | MP0004885_abnormal_endolymph | 0.26911807 |
139 | MP0001299_abnormal_eye_distance/ | 0.25713180 |
140 | MP0003763_abnormal_thymus_physiology | 0.25350997 |
141 | MP0002092_abnormal_eye_morphology | 0.25310403 |
142 | MP0003315_abnormal_perineum_morphology | 0.24068452 |
143 | MP0003567_abnormal_fetal_cardiomyocyte | 0.23238521 |
144 | MP0008438_abnormal_cutaneous_collagen | 0.22596296 |
145 | MP0005197_abnormal_uvea_morphology | 0.22141445 |
146 | MP0002697_abnormal_eye_size | 0.21144041 |
147 | MP0000371_diluted_coat_color | 0.20908191 |
148 | MP0002234_abnormal_pharynx_morphology | 0.19146084 |
149 | MP0002006_tumorigenesis | 0.18922102 |
150 | MP0000462_abnormal_digestive_system | 0.18131794 |
151 | MP0001853_heart_inflammation | 0.16807487 |
152 | MP0008789_abnormal_olfactory_epithelium | 0.16071561 |
153 | MP0003755_abnormal_palate_morphology | 0.15519080 |
154 | MP0002877_abnormal_melanocyte_morpholog | 0.15412666 |
155 | MP0000685_abnormal_immune_system | 0.15246587 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Palmoplantar hyperkeratosis (HP:0000972) | 8.17733189 |
2 | Palmar hyperkeratosis (HP:0010765) | 7.79306858 |
3 | Intrahepatic cholestasis (HP:0001406) | 7.17917791 |
4 | Erythema (HP:0010783) | 7.17783597 |
5 | Deep venous thrombosis (HP:0002625) | 6.81591211 |
6 | Plantar hyperkeratosis (HP:0007556) | 6.69297428 |
7 | Conjunctival hamartoma (HP:0100780) | 6.56103402 |
8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.51684447 |
9 | Prolonged partial thromboplastin time (HP:0003645) | 6.15120265 |
10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.09321299 |
11 | Hypobetalipoproteinemia (HP:0003563) | 5.90201223 |
12 | Complement deficiency (HP:0004431) | 5.87693862 |
13 | Xanthomatosis (HP:0000991) | 5.87356247 |
14 | Thick nail (HP:0001805) | 5.28259902 |
15 | Abnormality of secondary sexual hair (HP:0009888) | 5.02137582 |
16 | Abnormality of the axillary hair (HP:0100134) | 5.02137582 |
17 | Hyperlipoproteinemia (HP:0010980) | 4.93255344 |
18 | Woolly hair (HP:0002224) | 4.90263685 |
19 | Congenital ichthyosiform erythroderma (HP:0007431) | 4.80641728 |
20 | Fragile nails (HP:0001808) | 4.67628360 |
21 | Abnormality of complement system (HP:0005339) | 4.57988072 |
22 | Alopecia of scalp (HP:0002293) | 4.53251650 |
23 | Hypolipoproteinemia (HP:0010981) | 4.39350410 |
24 | Onycholysis (HP:0001806) | 4.39076108 |
25 | Hamartoma of the eye (HP:0010568) | 4.37154172 |
26 | Epidermoid cyst (HP:0200040) | 4.26621652 |
27 | Palmoplantar keratoderma (HP:0000982) | 4.26537094 |
28 | Joint hemorrhage (HP:0005261) | 4.23514894 |
29 | Fat malabsorption (HP:0002630) | 4.13070166 |
30 | Abnormality of the common coagulation pathway (HP:0010990) | 4.07292712 |
31 | Hyperammonemia (HP:0001987) | 4.00269453 |
32 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.94722989 |
33 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.93908787 |
34 | Increased IgE level (HP:0003212) | 3.92820472 |
35 | Hyperglycinemia (HP:0002154) | 3.82903212 |
36 | Abnormal blistering of the skin (HP:0008066) | 3.81443436 |
37 | Hypoalphalipoproteinemia (HP:0003233) | 3.81106091 |
38 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.78513101 |
39 | Ketosis (HP:0001946) | 3.68070045 |
40 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.64892781 |
41 | Eczematoid dermatitis (HP:0000976) | 3.62544427 |
42 | Conjugated hyperbilirubinemia (HP:0002908) | 3.52319341 |
43 | Abnormality of methionine metabolism (HP:0010901) | 3.51462671 |
44 | Abnormality of the intrinsic pathway (HP:0010989) | 3.47023176 |
45 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.46844362 |
46 | Hyperglycinuria (HP:0003108) | 3.44366579 |
47 | Hypoglycemic coma (HP:0001325) | 3.42721946 |
48 | Gangrene (HP:0100758) | 3.39909278 |
49 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.39834956 |
50 | Abnormality of glycine metabolism (HP:0010895) | 3.39834956 |
51 | Steatorrhea (HP:0002570) | 3.27933613 |
52 | Hypohidrosis (HP:0000966) | 3.23241200 |
53 | Sparse scalp hair (HP:0002209) | 3.16915721 |
54 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.13915654 |
55 | Aplasia of the phalanges of the hand (HP:0009802) | 3.13915654 |
56 | Aplasia involving bones of the extremities (HP:0009825) | 3.13915654 |
57 | Hypercholesterolemia (HP:0003124) | 3.12122306 |
58 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.11906049 |
59 | Abnormality of the salivary glands (HP:0010286) | 3.11528636 |
60 | Systemic lupus erythematosus (HP:0002725) | 3.03184454 |
61 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.01956131 |
62 | Erythroderma (HP:0001019) | 3.00579007 |
63 | Pili torti (HP:0003777) | 2.98106036 |
64 | Lip pit (HP:0100267) | 2.96603017 |
65 | Abnormal hair laboratory examination (HP:0003328) | 2.93155605 |
66 | Abnormality of nail color (HP:0100643) | 2.89546230 |
67 | Hyperbilirubinemia (HP:0002904) | 2.86980070 |
68 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.85424161 |
69 | Hypochromic microcytic anemia (HP:0004840) | 2.84028442 |
70 | Nail dystrophy (HP:0008404) | 2.78344825 |
71 | Absent eyelashes (HP:0000561) | 2.76488542 |
72 | Myocardial infarction (HP:0001658) | 2.75759139 |
73 | Sparse eyelashes (HP:0000653) | 2.72050563 |
74 | Vascular calcification (HP:0004934) | 2.70285217 |
75 | Delayed CNS myelination (HP:0002188) | 2.68437967 |
76 | Abnormality of nucleobase metabolism (HP:0010932) | 2.67898640 |
77 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.67460294 |
78 | Nasolacrimal duct obstruction (HP:0000579) | 2.66528357 |
79 | Oral leukoplakia (HP:0002745) | 2.63221166 |
80 | Ketoacidosis (HP:0001993) | 2.60207356 |
81 | Spontaneous abortion (HP:0005268) | 2.59990469 |
82 | Cholecystitis (HP:0001082) | 2.59465875 |
83 | Abnormal gallbladder physiology (HP:0012438) | 2.59465875 |
84 | Natal tooth (HP:0000695) | 2.51909118 |
85 | Hamartoma (HP:0010566) | 2.51516826 |
86 | Hepatocellular carcinoma (HP:0001402) | 2.50560692 |
87 | Conical tooth (HP:0000698) | 2.50414891 |
88 | Pruritus (HP:0000989) | 2.48862572 |
89 | Melanocytic nevus (HP:0000995) | 2.48654091 |
90 | Amyloidosis (HP:0011034) | 2.47999410 |
91 | Abnormality of permanent molar morphology (HP:0011071) | 2.47973642 |
92 | Abnormality of the dental root (HP:0006486) | 2.47973642 |
93 | Taurodontia (HP:0000679) | 2.47973642 |
94 | Abnormality of purine metabolism (HP:0004352) | 2.45894935 |
95 | Dry hair (HP:0011359) | 2.45682024 |
96 | Abnormality of serum amino acid levels (HP:0003112) | 2.44907084 |
97 | Cardiovascular calcification (HP:0011915) | 2.41009476 |
98 | Hypergammaglobulinemia (HP:0010702) | 2.40012054 |
99 | Advanced eruption of teeth (HP:0006288) | 2.39192428 |
100 | Neonatal onset (HP:0003623) | 2.39146178 |
101 | Hyperhidrosis (HP:0000975) | 2.36541038 |
102 | Skin nodule (HP:0200036) | 2.34898301 |
103 | Metabolic acidosis (HP:0001942) | 2.34194171 |
104 | Mitral stenosis (HP:0001718) | 2.33410135 |
105 | Abnormality of molar morphology (HP:0011070) | 2.30701661 |
106 | Abnormality of molar (HP:0011077) | 2.30701661 |
107 | Abnormality of the lacrimal duct (HP:0011481) | 2.29217339 |
108 | Dicarboxylic aciduria (HP:0003215) | 2.25821156 |
109 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.25821156 |
110 | Malnutrition (HP:0004395) | 2.24429793 |
111 | Abnormal gallbladder morphology (HP:0012437) | 2.23678635 |
112 | Corneal erosion (HP:0200020) | 2.23346808 |
113 | Hypophosphatemic rickets (HP:0004912) | 2.22270764 |
114 | Neonatal death (HP:0003811) | 2.21423632 |
115 | Abnormality of the dental pulp (HP:0006479) | 2.21277828 |
116 | Xerostomia (HP:0000217) | 2.21117208 |
117 | Parakeratosis (HP:0001036) | 2.20930654 |
118 | Ectropion (HP:0000656) | 2.20576111 |
119 | Follicular hyperkeratosis (HP:0007502) | 2.20388340 |
120 | Cholelithiasis (HP:0001081) | 2.19410446 |
121 | Selective tooth agenesis (HP:0001592) | 2.18873381 |
122 | Spastic diplegia (HP:0001264) | 2.18570555 |
123 | Hypotrichosis (HP:0001006) | 2.17965401 |
124 | Lethargy (HP:0001254) | 2.17605959 |
125 | Right ventricular cardiomyopathy (HP:0011663) | 2.17089112 |
126 | Rickets (HP:0002748) | 2.16231702 |
127 | Gout (HP:0001997) | 2.13434409 |
128 | Hypoglycemic seizures (HP:0002173) | 2.11946859 |
129 | Brushfield spots (HP:0001088) | 2.10262407 |
130 | Abnormality of hair growth rate (HP:0011363) | 2.07953183 |
131 | Slow-growing hair (HP:0002217) | 2.07953183 |
132 | Cerebral edema (HP:0002181) | 2.07228530 |
133 | Acanthocytosis (HP:0001927) | 2.06880920 |
134 | Milia (HP:0001056) | 2.05871415 |
135 | Irritability (HP:0000737) | 2.05531080 |
136 | Split foot (HP:0001839) | 2.03784973 |
137 | Late onset (HP:0003584) | 2.01726464 |
138 | Hypoplastic labia majora (HP:0000059) | 2.00139167 |
139 | Abnormality of the nasolacrimal system (HP:0000614) | 1.99660155 |
140 | Septate vagina (HP:0001153) | 1.98616039 |
141 | Absent hair (HP:0002298) | 1.98173932 |
142 | Sensorimotor neuropathy (HP:0007141) | 1.97191803 |
143 | Gingival bleeding (HP:0000225) | 1.96959810 |
144 | Lack of skin elasticity (HP:0100679) | 1.95765587 |
145 | Blepharitis (HP:0000498) | 1.95620892 |
146 | Abnormality of the gallbladder (HP:0005264) | 1.95037318 |
147 | Hydroxyprolinuria (HP:0003080) | 1.93762648 |
148 | Abnormality of proline metabolism (HP:0010907) | 1.93762648 |
149 | Abnormality of the Achilles tendon (HP:0005109) | 1.90345544 |
150 | Pancreatitis (HP:0001733) | 1.87159518 |
151 | Glomerulonephritis (HP:0000099) | 1.86582997 |
152 | Menorrhagia (HP:0000132) | 1.85612261 |
153 | Oligodontia (HP:0000677) | 1.85486169 |
154 | Curly hair (HP:0002212) | 1.85160571 |
155 | Opisthotonus (HP:0002179) | 1.83604210 |
156 | Broad alveolar ridges (HP:0000187) | 1.83243252 |
157 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.82338188 |
158 | Ridged nail (HP:0001807) | 1.81367204 |
159 | Abnormality of the labia majora (HP:0012881) | 1.80528013 |
160 | Abnormal cartilage morphology (HP:0002763) | 1.79968729 |
161 | Acanthosis nigricans (HP:0000956) | 1.78984922 |
162 | Duplicated collecting system (HP:0000081) | 1.78534159 |
163 | Dehydration (HP:0001944) | 1.78381343 |
164 | Brittle hair (HP:0002299) | 1.76196307 |
165 | Neonatal short-limb short stature (HP:0008921) | 1.74676081 |
166 | Skin ulcer (HP:0200042) | 1.71927825 |
167 | Alacrima (HP:0000522) | 1.71066401 |
168 | Laryngomalacia (HP:0001601) | 1.69936200 |
169 | Dry skin (HP:0000958) | 1.65651461 |
170 | Pustule (HP:0200039) | 1.64471915 |
171 | Abnormality of the alveolar ridges (HP:0006477) | 1.57563451 |
172 | Depressed nasal tip (HP:0000437) | 1.57426451 |
173 | Anonychia (HP:0001798) | 1.52120565 |
174 | Coarse hair (HP:0002208) | 1.51666377 |
175 | Abnormality of the renal collecting system (HP:0004742) | 1.47886391 |
176 | Seborrheic dermatitis (HP:0001051) | 1.43847676 |
177 | Ventricular tachycardia (HP:0004756) | 1.43016904 |
178 | Abnormality of incisor morphology (HP:0011063) | 1.41983818 |
179 | Hypoplasia of dental enamel (HP:0006297) | 1.40886559 |
180 | Coronal craniosynostosis (HP:0004440) | 1.40608804 |
181 | Recurrent corneal erosions (HP:0000495) | 1.40605181 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 5.73952786 |
2 | STK24 | 5.60324249 |
3 | EPHA2 | 5.12977349 |
4 | EEF2K | 5.12838428 |
5 | ERN1 | 4.58184689 |
6 | FGFR4 | 4.15399710 |
7 | SIK1 | 4.09085181 |
8 | ERBB4 | 3.48065442 |
9 | MST1R | 3.39667809 |
10 | TGFBR1 | 3.13322503 |
11 | MAP2K4 | 2.60781038 |
12 | TAOK3 | 2.32083907 |
13 | PIK3CG | 2.29164377 |
14 | INSRR | 2.27403827 |
15 | MAP3K2 | 2.16312729 |
16 | LATS1 | 2.05136210 |
17 | TRPM7 | 1.82740847 |
18 | MAPKAPK3 | 1.79201648 |
19 | MAP3K3 | 1.73437036 |
20 | MAPK11 | 1.66633768 |
21 | MAPKAPK5 | 1.64853983 |
22 | MAP3K7 | 1.64145291 |
23 | ICK | 1.64060580 |
24 | PTK6 | 1.56821941 |
25 | FGFR2 | 1.54619216 |
26 | SGK223 | 1.50069090 |
27 | SGK494 | 1.50069090 |
28 | TYK2 | 1.47705188 |
29 | RPS6KB2 | 1.43365017 |
30 | FGFR1 | 1.38144725 |
31 | MAP3K11 | 1.37313810 |
32 | TRIB3 | 1.32843096 |
33 | DYRK1B | 1.32653321 |
34 | MAP3K14 | 1.31200130 |
35 | AKT3 | 1.30579906 |
36 | STK38L | 1.25578660 |
37 | WNK1 | 1.23186129 |
38 | CDK12 | 1.20875204 |
39 | JAK2 | 1.17600229 |
40 | ABL2 | 1.13042612 |
41 | MAP3K10 | 1.11229746 |
42 | PKN2 | 1.10096682 |
43 | ERBB2 | 1.05644804 |
44 | NEK9 | 1.05389820 |
45 | RPS6KB1 | 1.04074672 |
46 | PRKAA2 | 1.03966347 |
47 | TBK1 | 1.02364827 |
48 | SGK2 | 1.01118647 |
49 | PINK1 | 0.96977515 |
50 | MET | 0.94805267 |
51 | MAP2K3 | 0.94001759 |
52 | JAK1 | 0.93145377 |
53 | FRK | 0.92685974 |
54 | CDK6 | 0.89897723 |
55 | MAPK4 | 0.89752641 |
56 | RIPK1 | 0.89178307 |
57 | LATS2 | 0.88794299 |
58 | PKN1 | 0.86614540 |
59 | PRPF4B | 0.85595644 |
60 | FLT3 | 0.84598668 |
61 | ITK | 0.83573721 |
62 | DAPK2 | 0.83456453 |
63 | SGK3 | 0.80956701 |
64 | EPHB1 | 0.77895637 |
65 | PAK3 | 0.75932248 |
66 | MAPK15 | 0.73138972 |
67 | PRKCZ | 0.72790530 |
68 | EPHA3 | 0.71684793 |
69 | MAP2K6 | 0.70490644 |
70 | IRAK1 | 0.70311664 |
71 | MAPK12 | 0.69827950 |
72 | MTOR | 0.69289321 |
73 | GRK5 | 0.69179945 |
74 | NLK | 0.68853233 |
75 | GRK6 | 0.68601838 |
76 | PRKACG | 0.67221463 |
77 | MAP2K1 | 0.65853358 |
78 | FER | 0.65574969 |
79 | MAP3K5 | 0.64001248 |
80 | PIK3CA | 0.59338565 |
81 | SYK | 0.58886546 |
82 | FGFR3 | 0.57526471 |
83 | MAPKAPK2 | 0.57348084 |
84 | EPHA4 | 0.56938815 |
85 | TGFBR2 | 0.56484532 |
86 | CAMK2G | 0.56169039 |
87 | MAP3K9 | 0.55734909 |
88 | IKBKE | 0.55716050 |
89 | SGK1 | 0.55591446 |
90 | GSK3A | 0.54823590 |
91 | KDR | 0.54456827 |
92 | GRK7 | 0.53854451 |
93 | MAP3K1 | 0.53544483 |
94 | MOS | 0.53477712 |
95 | STK38 | 0.52698476 |
96 | PDGFRB | 0.51407073 |
97 | IRAK2 | 0.50644932 |
98 | ADRBK1 | 0.49160139 |
99 | PTK2 | 0.46983463 |
100 | PRKCH | 0.45938587 |
101 | IRAK3 | 0.45807207 |
102 | TIE1 | 0.44675245 |
103 | CAMK1D | 0.44244249 |
104 | PRKCQ | 0.43668057 |
105 | KIT | 0.43462026 |
106 | TYRO3 | 0.43440936 |
107 | DYRK3 | 0.43149631 |
108 | MINK1 | 0.42001092 |
109 | WNK4 | 0.40688832 |
110 | BMX | 0.40551139 |
111 | PRKCE | 0.40439401 |
112 | PRKCG | 0.39364977 |
113 | CSK | 0.39195805 |
114 | LRRK2 | 0.38601579 |
115 | EGFR | 0.38365474 |
116 | MST4 | 0.36778403 |
117 | MAPK7 | 0.35669226 |
118 | PIM2 | 0.35363148 |
119 | PRKAA1 | 0.35221420 |
120 | ABL1 | 0.35187254 |
121 | BCR | 0.34782189 |
122 | PDGFRA | 0.34480399 |
123 | MAP3K6 | 0.34270294 |
124 | CSNK1D | 0.34224101 |
125 | PRKCA | 0.33560229 |
126 | IGF1R | 0.33315642 |
127 | STK3 | 0.32339040 |
128 | RET | 0.31637525 |
129 | STK10 | 0.31233022 |
130 | BRD4 | 0.30286309 |
131 | TAOK1 | 0.30231901 |
132 | NEK6 | 0.29786463 |
133 | BMPR2 | 0.29711331 |
134 | PRKD1 | 0.28859928 |
135 | MAP3K12 | 0.27838500 |
136 | MARK2 | 0.27264538 |
137 | GRK1 | 0.27181100 |
138 | CDK3 | 0.27078333 |
139 | CDK7 | 0.26966784 |
140 | CSNK1E | 0.25801664 |
141 | IKBKB | 0.23677251 |
142 | CAMK4 | 0.23386080 |
143 | MAPK9 | 0.22379065 |
144 | BRSK2 | 0.21503265 |
145 | PRKD2 | 0.20717875 |
146 | CHUK | 0.20093348 |
147 | DDR2 | 0.18001808 |
148 | PBK | 0.17765191 |
149 | IRAK4 | 0.15659331 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.88307252 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.25687170 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.20541181 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.10194655 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.01426222 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.87895328 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.65837320 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.56219566 |
9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49012634 |
10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.47664437 |
11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.45021670 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34693049 |
13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.13865173 |
14 | Peroxisome_Homo sapiens_hsa04146 | 2.13178262 |
15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.10237315 |
16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.07074511 |
17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.04793500 |
18 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.97438851 |
19 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.88977656 |
20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.87157022 |
21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86059287 |
22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.84739807 |
23 | Retinol metabolism_Homo sapiens_hsa00830 | 1.81907222 |
24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.81800094 |
25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80293596 |
26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79852747 |
27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.77271691 |
28 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.69025521 |
29 | ABC transporters_Homo sapiens_hsa02010 | 1.68064764 |
30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.65403742 |
31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.58134494 |
32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.57496972 |
33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55394553 |
34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.54460926 |
35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.53244846 |
36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.49631287 |
37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.48171761 |
38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.43626174 |
39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.42433394 |
40 | Bile secretion_Homo sapiens_hsa04976 | 1.42106097 |
41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.41859306 |
42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41359114 |
43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.36099589 |
44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.34331351 |
45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.31729406 |
46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30849208 |
47 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20428523 |
48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.17306102 |
49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.16567040 |
50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.10427064 |
51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.08185418 |
52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.08027530 |
53 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.06853186 |
54 | Long-term depression_Homo sapiens_hsa04730 | 1.06126427 |
55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.04186581 |
56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02962161 |
57 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.97751500 |
58 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.97305388 |
59 | Carbon metabolism_Homo sapiens_hsa01200 | 0.97268279 |
60 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95832172 |
61 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94277155 |
62 | Phototransduction_Homo sapiens_hsa04744 | 0.94157316 |
63 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.90216024 |
64 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.88097174 |
65 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86325951 |
66 | Renin secretion_Homo sapiens_hsa04924 | 0.83809347 |
67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.83432395 |
68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81822549 |
69 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81104391 |
70 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.80155159 |
71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.78419231 |
72 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.78100084 |
73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.77556130 |
74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76268184 |
75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.72645916 |
76 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.71157690 |
77 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.68828759 |
78 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.68393647 |
79 | Lysine degradation_Homo sapiens_hsa00310 | 0.66001727 |
80 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.64219892 |
81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63006368 |
82 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62232846 |
83 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.60649127 |
84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59806295 |
85 | Prion diseases_Homo sapiens_hsa05020 | 0.58709268 |
86 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.56752182 |
87 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56640376 |
88 | Adherens junction_Homo sapiens_hsa04520 | 0.56604956 |
89 | Platelet activation_Homo sapiens_hsa04611 | 0.56574677 |
90 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.55478056 |
91 | Tight junction_Homo sapiens_hsa04530 | 0.50854663 |
92 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.50317159 |
93 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.48277816 |
94 | Endocytosis_Homo sapiens_hsa04144 | 0.46553306 |
95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45974535 |
96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45083293 |
97 | Melanogenesis_Homo sapiens_hsa04916 | 0.42681283 |
98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.42066537 |
99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38479786 |
100 | Thyroid cancer_Homo sapiens_hsa05216 | 0.37992543 |
101 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.37304328 |
102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35761868 |
103 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.34650097 |
104 | Glioma_Homo sapiens_hsa05214 | 0.34342832 |
105 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34081829 |
106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33134681 |
107 | Long-term potentiation_Homo sapiens_hsa04720 | 0.32939936 |
108 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.29971227 |
109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29700504 |
110 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.26500159 |
111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25638568 |
112 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.25637684 |
113 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.25217886 |
114 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.25062630 |
115 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.24976882 |
116 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.24198081 |
117 | Insulin resistance_Homo sapiens_hsa04931 | 0.23783522 |
118 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23741947 |
119 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.22847764 |
120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22292329 |
121 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.15741248 |
122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.09045664 |
123 | Galactose metabolism_Homo sapiens_hsa00052 | 0.08391586 |
124 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07726802 |
125 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.07401894 |
126 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2352657 |
127 | Mineral absorption_Homo sapiens_hsa04978 | -0.2282886 |
128 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2217557 |
129 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1999535 |
130 | Pertussis_Homo sapiens_hsa05133 | -0.1981557 |
131 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1945494 |
132 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1934874 |
133 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1856531 |
134 | Lysosome_Homo sapiens_hsa04142 | -0.1819358 |
135 | Bladder cancer_Homo sapiens_hsa05219 | -0.1600338 |
136 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1529679 |
137 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1325555 |
138 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1315151 |
139 | Amoebiasis_Homo sapiens_hsa05146 | -0.1126641 |
140 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0821385 |
141 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0570466 |
142 | Hepatitis C_Homo sapiens_hsa05160 | -0.0515893 |
143 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0402252 |
144 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0151374 |